A b s t r a c t
Polyomavirus type BK (BKV), a nonenveloped, doublestranded DNA virus, is an important cause of allograft failure in renal transplant recipients. [1] [2] [3] [4] [5] [6] [7] Serologic studies have shown that BKV infection occurs primarily during childhood at a median age of 4 to 5 years. 3 By adulthood, 46% to 94% of the population is seropositive depending on the age group and geographic location of the population studied. 3 Although BKV generally remains latent in the kidney and uroepithelium, asymptomatic reactivation and intermittent shedding of BKV in urine can occur in immunocompromised persons such as patients with HIV infection or patients undergoing immunosuppressive therapy. 4, 5, 8, 9 Renal transplant recipients in particular have been shown to be susceptible to reactivation of latent BKV infection when exposed to potent immunosuppressive drugs and are at risk of polyomavirus-associated interstitial nephropathy (PVAN). 5, 10 Cytology, serum polymerase chain reaction (PCR), and renal biopsy in situ hybridization (ISH) have been used to assess whether reactivation of BKV has occurred. 1, 2, 5, 7, 11 These tests are in common clinical use because they help with early detection of BKV reactivation and reduction of immunosuppressive therapy to prevent severe graft injury or graft loss due to PVAN. 6 Between 20% and 30% of kidney transplant recipients have detectable BKV reactivation by urine cytologic analysis during the first posttransplant year and are at elevated risk for subsequent development of biopsy-proven PVAN. 5 Although cytology is valuable in assessing whether BKVinfected cells are present in urine specimens, BKV infected "decoy cells" can mimic high-grade malignancy in urine specimens being assessed for urothelial carcinoma (UC). 12 Digital image analysis (DIA) and fluorescence in situ hybridization (FISH) are widely accepted ancillary tests used for the evaluation of urine cytologic specimens for UC. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The finding of aneuploid or aneusomic cells by DIA or FISH generally is taken as evidence of UC or other malignancy. Previous studies have shown that BKV causes aneuploid (false-positive) DIA results in urine specimens from patients who do not have UC or another malignancy. 23 However, it is unclear whether BKV-infected cells produce false-positive FISH results (aneusomy).
The UroVysion FISH assay (Vysis, Downers Grove, IL) is a US Food and Drug Administration-approved test for the detection of recurrent bladder cancer in urine specimens. The UroVysion probe set consists of directly labeled DNA probes to the pericentromeric regions of chromosomes 3 (CEP3), 7 (CEP7), and 17 (CEP17) and to the chromosomal band 9p21 (LSI 9p21). 21 Visualization of these probes by fluorescence microscopy is used to determine whether there are chromosome abnormalities in urinary cells that are consistent with a diagnosis of UC.
In the present study, we evaluated urine specimens from renal transplant recipients with routine cytology, DIA, and FISH. These findings were correlated with BKV ISH and serum PCR results. The goal of the study was to determine whether BKV-infected (decoy) cells in urine generate aneusomic (false-positive) FISH results.
Materials and Methods

Patients
As approved by the Mayo Clinic Institutional Review Board (Rochester, MN), residual urine specimens were obtained from 38 renal transplant recipients (mean age, 57 years; range, 28-79 years) that were assessed for BKV with routine cytology. Because the goal of this study was to determine whether BKV infection produces false-positive FISH results, we used urine specimens from 32 consecutive patients whose urine cytology had demonstrated decoy cells. For positive and negative control samples, respectively, we included 2 specimens from patients who had UC with positive urine cytology, DIA, and FISH results and 6 specimens from renal transplant recipients who had no evidence of BKV infection (ie, no decoy cells by urine cytology). All analyses were performed and interpreted without knowledge of the patients' laboratory and clinical findings.
Routine Cytology
Urine specimens (mean volume, 50 mL; range 20-90 mL) were concentrated at 500g for 10 minutes. After decanting the supernatant, the sediment was mixed with 200 µL (men) or 400 µL (women) of a 2% carbowax solution. Two Cytospin slides (Shandon, Pittsburgh, PA) were prepared with 200 µL of urine-carbowax mixture using a Cytospin 3 cytocentrifuge (Shandon) followed by Papanicolaou staining. BKV-infected cells were quantified as the number of infected cells per 10 high-power fields (hpf) using a 40× lens. Decoy cells were defined as cells with intranuclear, homogeneous, glassy inclusions or enlarged cells with an apparent empty nucleus. 24 Forty (20 from each slide) hpf were analyzed to obtain a mean BKV value per 10 hpf.
FISH and DIA
Residual urine cytology specimens were shaken gently and split evenly for DIA and FISH analysis. For FISH, cells were isolated and hybridized as previously described. 13, 21 Slides also were assessed as previously described to determine whether the sample was positive or negative for UC. 13 All specimens were evaluated by 1 of 3 clinical FISH cytotechnologists experienced in the evaluation of UroVysion slides. The cytotechnologists had no knowledge of the patients' clinical or pathologic findings.
For DIA, cells were isolated from urine by centrifugation at 500g for 10 minutes. The cell pellet then was gently agitated with a vortex, added to a Non-GYN PreservCyt vial (Cytyc, Boxborough, MA), and processed using a ThinPrep Processor (Cytyc). Processed slides were fixed in 95% ethanol for 15 minutes and allowed to air dry. The slides then were stained with the Feulgen dye, which binds DNA in stoichiometric fashion. 25 DNA ploidy assessment was performed using the CAS 200 image analyzer (Bacus Laboratories, Lombard, IL). All analyses were performed by board-certified cytotechnologists trained in DIA. Up to 50 of the most atypical-appearing nonsquamous nuclei from each sample were analyzed using a 40× objective. Measurement of DNA content was standardized using rat hepatocytes (Bacus Laboratories) as external control samples. The DNA ploidy status of individual nuclei was determined with the Quantitative DNA Analysis program (Bacus Laboratories) on the CAS 200 system. Nuclei were categorized as diploid (DNA index between 0.95 and 1.10) ❚Image 1A❚, S-phase/aneuploid (DNA index between 1.11 and 1.89), tetraploid (DNA index between 1.90 and 2.10), or hypertetraploid (DNA index >2.10). A case was interpreted as diploid if the peak DNA index was between 0.95 and 1.10 and there was no clonal population of cells beyond 1.10 ❚Image 1B❚ and aneuploid if there was a significant population of cells with a peak DNA index greater than 1.11 not residing in the tetraploid range ❚Image 1E❚ and ❚Image 1H❚. The percentage of nondiploid cells, which included cells demonstrating aneuploid, tetraploid, or hypertetraploid DNA content, also was recorded.
PCR and ISH
In addition to urine cytology, patients also were assessed for BKV infection with quantitative serum PCR and ISH on renal allograft biopsy specimens. Quantitative plasma PCR was performed by Focus Diagnostics (Cypress, CA). This PCR assay provides BK-specific quantification of viral DNA in the linear range of 200 to 200 million copies per milliliter. 26 A result of 200 copies per milliliter or more of specimen was considered positive for this study. A result of less than 200 was considered negative for BKV and assigned a value of 0 BKV cells per milliliter of serum for the purpose of statistical analysis. Renal allograft biopsy specimens were assessed for the presence of BKV infection with ISH as previously described. 11
Statistics
Statistical analyses were performed with SPSS 11.5 for Windows (SPSS, Chicago, IL). The significance of associations was determined using the Mann-Whitney test and Pearson correlation, as appropriate. All tests were 2-tailed, and P values less than .05 were considered statistically significant.
Results
The FISH, cytology, DIA, PCR, and biopsy ISH findings for the 38 renal transplant recipients and 2 positive control subjects (ie, non-renal transplant recipients with UC) are shown in ❚Table 1❚. Among the renal transplant recipient specimens selected for this study, 32 (84.2%) had evidence of BKV infection by cytology ❚Image 1D❚ and ❚Image 1G❚, 30 (78.9%) had aneuploid results by DIA (Image 1E and Image 1H), and 22 (57.9%) had positive serum PCR results (ie, ≥200 In the 32 renal transplant recipients found to have BKV present in their urine, 28 (87.5%) of the specimens were disomic (ie, negative for chromosome abnormalities) ❚Image 1C❚ and 4 (12.5%) were aneusomic by FISH. Of the 4 patients with FISH abnormalities, all were men and 52 years of age or older ( Table 1 30, 31 A previous study has shown that aneuploid DIA results were observed when assessing urine specimens from BKV-infected patients without UC. 23 This suggests that BKV infection can give false-positive results if DIA is used to assess for UC.
The goal of the present study was to determine whether BKV infections also cause false-positive FISH results. To assess whether BKV causes aneusomic FISH results, we primarily evaluated urine specimens from renal transplant recipients with evidence of BKV infection by urine cytology but also included 6 additional samples from renal transplant recipients without evidence of BKV infection.
Our data suggest that positive FISH results are observed in a small proportion of renal transplant recipients (12.5% in this study) with BKV (decoy) cells, and renal transplant recipients with positive FISH results had significantly higher numbers of decoy cells in their urine than patients with negative FISH results. Of the 6 patients with the highest number of BKV cells per 10 hpf, 4 were found to be positive for FISH. None of the 4 patients with a positive FISH result currently has clinical evidence of UC or other malignancy. Thus, at this time, the FISH results seem to have been false-positive. The FISH-positive specimens demonstrated different abnormal signal patterns, with 2 specimens demonstrating 9p21 deletion (specimens 6 and 24; Image 1F), 1 demonstrating polysomy (ie, chromosomal gains; specimen 23, Image 1I), and 1 demonstrating a trisomy 7 signal pattern (specimen 38). All three of these FISH signal patterns have been previously identified in patients with UC. 14 We did not expect aneusomic FISH results in specimens infected with BKV because the detection of aneusomic signal patterns with UroVysion has been shown to have high specificity for the detection of malignancy. However, it is a wellestablished fact that immunocompromised patients are at increased risk for malignant neoplasms even though, to date, BKV infection has not been associated clearly with human malignancy. 3, 14, 19, 20, 31, 32 The positive FISH results observed in this study might represent false-positive FISH results or the detection of a neoplastic lesion before it manifests clinically. Support for the latter possibility comes from previous studies that have shown that FISH with UroVysion sometimes is able to detect recurrent bladder cancer months before it is detectable clinically. 20, 31, 32 During assessment of the 2 specimens demonstrating only 9p21 deletion, we observed that the 3 pericentromeric probes (CEP3, CEP7, and CEP17), which usually give strong signals, were weak in the same cells showing 9p21 homozygous deletion (Image 1F). It is possible that high intranuclear BKV copy numbers interfere with the hybridization of these probes to their targets, which then leads to weak signals (9p21 especially) that are misinterpreted as 9p21 loss. The region that the 9p21 probe hybridizes is small compared with the size of the region that the pericentromeric probes hybridize (repetitive α-satellite sequences). Perhaps there is interference with the 9p21 probe hybridization to a point where it is not visible, while the larger pericentromeric probes in the same cells have weaker visible signals.
However, the explanation for 9p21 deletions by FISH does not explain the FISH-positive cases demonstrating polysomy and trisomy 7. Although these patients are not known currently to have UC or other malignancy, the positive FISH results observed in these 2 cases suggest 1 of 2 possibilities: the patients have a subclinical neoplasm of the genitourinary tract or a high titer of BKV induces chromosomal changes that do not indicate the presence of a malignancy or somehow are eliminated from the body via the urine before a tumor develops. Previous studies have shown that renal transplant recipients are at increased risk of developing a variety of cancers, including UC, likely secondary to immunosuppresion. 3, [33] [34] [35] [36] However, in renal transplant recipients, the pathogenic role of BKV and immunosuppression is not understood clearly. 3 It is interesting to note that the only polysomic FISH result occurred in one of the oldest patients (75-year-old man) with the highest titer of urinary BKV cells by cytology. Furthermore, all patients with abnormal FISH results were men older than 50 years, and all FISH-positive results were seen in patients with some of the highest urinary BKV titers. The limited patient numbers in this study preclude definitive conclusions regarding the role of age, immune status, and viral titer in generating genetic alterations important for tumor pathogenesis, but this concept needs further study. The polysomic FISH case had the highest number of BKV cells noted by cytology with 52.5/10 hpf. However, the number of BKV copies per milliliter of serum by PCR was relatively low (1,600 copies) in comparison with high-titer samples from patients whose urine specimens did not exhibit polysomy (eg, specimens 2 and 3, Table 1 ). Review of this patient's history showed that he had a suprapubic prostatectomy in 1997 for prostatic hypertrophy with microscopic identification of clinically occult prostate cancer. Recurrent prostate cancer subsequently developed in 1999 and was treated with radiation therapy. The patient now has end-stage renal disease that is presumed to be due to obstructive uropathy from benign prostatic hypertrophy. Although there is no definitive evidence of recurrent prostatic cancer, it is possible that the polysomic cells in this sample represent recurrent cancer. We previously have identified patients with positive FISH results in our laboratory that had biopsy specimens demonstrating prostate cancer.
The patient with the trisomy 7 result also has no evidence of cancer at this time, but as is the case for the other patients with FISH-positive specimens in the study, the clinical follow-up has not necessarily focused on the identification of urinary tract neoplasia. Extended clinical follow-up of these patients will be required to determine whether the positive FISH cases are indeed false-positives or represent clinically undetected cancers.
Of the 32 specimens that demonstrated BKV by cytology, PCR detected BKV in the serum of 22 (68.8%), and ISH detected BKV infection in the renal biopsy specimens of 3 (27.3%) of 11. These findings are consistent with those of previous studies showing that cytology detects decoy cells more frequently than PCR detects viremia and/or biopsy shows viral nephropathy. 5 The data from this study also are consistent with those from previous studies showing that decoy cells are aneuploid by DIA. 23 We found that there was a correlation (R = 0.433; P < .01) between the number of decoy cells detected by cytology per 10 hpf and the percentage of aneuploid cells by DIA. This likely is due to the Feulgen stain reacting with viral and human DNA, resulting in histograms interpreted as aneuploid. 23, 37 The results of our study suggest that apparent false-positive FISH results are observed in only a small proportion (12.5%) of renal transplant recipients with BKV reactivation and seem to be confined to patients with heavy shedding of virally infected epithelial cells. Our clinical records to date demonstrate no evidence of a subsequent diagnosis of UC or other malignancy among the 4 FISH-positive patients. Nevertheless, it is clear that some renal transplant recipients are at increased risk for UC and consideration should be given to urologic evaluation or repeated urine cytology/FISH analysis following a period of reduced immunosuppression in appropriate cases. Patients with BKV reactivation should not be assessed for malignancy using the DIA method because nearly all cases with detectable amounts of BKV will demonstrate high percentages of aneuploid cells.
